Swedish Telecom Services and Carriers Stock News

OM:EPI A
OM:EPI AMachinery

Is Epiroc’s SEK 380m African Automation Order Altering The Investment Case For Epiroc (OM:EPI A)?

Epiroc AB recently announced it has secured a large SEK 380 million order in Africa for fully autonomous, cable-electric Pit Viper 275 E blasthole drill rigs, with deliveries already underway and scheduled to finish by the end of 2027. This contract highlights growing customer interest in zero-exhaust, automation-ready mining fleets that can enhance safety and productivity while reducing onsite emissions. We will now explore how this large African order for fully autonomous, cable-electric...
OM:SWED A
OM:SWED ABanks

Swedbank (OM:SWED A) Valuation Check After AGM Dividend Payout And Board Change

Swedbank (OM:SWED A) held its Annual General Meeting on 24 March 2026, where shareholders approved a total dividend of SEK 29.80 per share, including a SEK 9.35 special dividend, and elected Rikard Josefson to the board. See our latest analysis for Swedbank. Despite the AGM decisions on dividends and board changes, Swedbank's recent momentum has cooled, with a 1 month share price return of a 12.78% decline and a year to date share price return of a 6.45% decline, even as the 1 year total...
OM:LIAB
OM:LIABBuilding

Exploring Europe's Undiscovered Gems for March 2026

As geopolitical tensions and soaring energy prices weigh heavily on European markets, the pan-European STOXX Europe 600 Index has seen a notable decline of 3.79%, reflecting broader investor caution. Despite these challenges, opportunities may still exist within the small-cap segment, where companies with robust fundamentals and innovative growth strategies can stand out amid market volatility.
OM:EQT
OM:EQTCapital Markets

EQT (OM:EQT) FY 2025 Margin Slippage Tests Bullish High‑Growth Narrative

EQT (OM:EQT) FY 2025 results: revenue steady, EPS in focus EQT (OM:EQT) just posted its FY 2025 numbers with second half revenue of €1.4b and basic EPS of €0.33, alongside first half revenue of €1.3b and EPS of €0.29. Together, these figures set the tone for how you read the year as a whole. The company has seen revenue move from €1.4b and EPS of €0.42 in the second half of 2024 to €1.4b and EPS of €0.33 in the second half of 2025, while trailing twelve month EPS sits at €0.62 on revenue of...
OM:INVE A
OM:INVE ADiversified Financial

Assessing Investor (OM:INVE A) Valuation After Recent Share Price Pullback

Investor (OM:INVE A) shares have been moving without a clear single event catalyst, leaving you weighing mixed signals from recent returns, revenue and net income trends, and the stock’s current intrinsic discount. See our latest analysis for Investor. The recent pullback, including a 7% 30 day share price return and a 3% 7 day move, sits against a 4% year to date share price return and a 10.84% 1 year total shareholder return. This suggests that momentum has cooled after a stronger run. If...
OM:ERIC B
OM:ERIC BCommunications

Ericsson (OM:ERIC B) Valuation Check As 6G Collaborations Take Center Stage At Mobile World Congress 2026

Telefonaktiebolaget LM Ericsson (OM:ERIC B) put 6G firmly in the spotlight at Mobile World Congress 2026, using live demos and partner collaborations with Intel, Qualcomm, MediaTek and Apple to showcase AI-native network capabilities. See our latest analysis for Telefonaktiebolaget LM Ericsson. These high profile 6G and enterprise wireless announcements come after a 90 day share price return of 17.17% and a 1 year total shareholder return of 30.05%. This suggests momentum has recently been...
OM:BIOA B
OM:BIOA BBiotechs

How Strong Lecanemab Persistence Data At BioArctic (OM:BIOA B) Has Changed Its Investment Story

In March 2026, BioArctic and its partner Eisai presented new real-world and scientific data on Alzheimer’s drug lecanemab and BioArctic’s Parkinson’s research at the AD/PD Conference in Copenhagen, highlighting treatment persistence and mechanistic insights. The high proportion of early Alzheimer’s patients staying on lecanemab beyond 18 months, alongside BioArctic’s ongoing R&D presentations, underscores the company’s role in shaping emerging standards of care in neurodegenerative...
OM:PEAB B
OM:PEAB BConstruction

Peab (OM:PEAB B) Valuation Check As New Contracts And Larger Credit Facility Shape Investor Expectations

Peab (OM:PEAB B) has secured a series of new contracts across schools, hospitals, infrastructure and mining, alongside an SEK 8,000 million credit facility. This has prompted fresh attention on the stock’s recent performance and valuation. See our latest analysis for Peab. Despite an 11.3% 3 month share price return and a 23.2% 1 year total shareholder return, Peab’s shares have recently eased. The 30 day share price return is 9.3% and the 7 day return is 5.5%, suggesting some momentum has...
OM:SKA B
OM:SKA BConstruction

Skanska (OM:SKA B) Valuation Check After Major US And Swedish Contract Wins

Skanska (OM:SKA B) has secured several new construction contracts, including large projects in the US and Sweden. These deals add fresh volume to its order book across education, research, digital infrastructure and public-space development. See our latest analysis for Skanska. Despite these sizeable contract wins, the share price has a 30 day return of 11.77% and a year to date return decline of 5.24%, while the 1 year total shareholder return is 4.3% and the 3 year total shareholder return...
OM:EQT
OM:EQTCapital Markets

Has EQT (OM:EQT) Pulled Back Enough After Recent Share Price Weakness?

Wondering if EQT at a last close of kr272.60 is starting to look attractive or still has more room to fall before the price makes sense. The share price has been under pressure recently, with a 2.3% decline over the last 7 days, 7.9% over 30 days, and 23.9% year to date, even though the 3 year return sits at 42.0% and the 5 year return at 5.0%. This mix of shorter term weakness and longer term gains has pushed EQT back onto many investors' watchlists, especially as market attention rotates...
OM:KINV B
OM:KINV BDiversified Financial

Kinnevik (OM:KINV B) Valuation Check As Rubin Ritter Takes Over As Interim CEO

Kinnevik (OM:KINV B) shares are in focus after the company named board member Rubin Ritter as interim CEO with immediate effect, while the search for a permanent chief executive continues. See our latest analysis for Kinnevik. The CEO change comes after a period of weak momentum, with a 30 day share price return decline of 24.09% and a 1 year total shareholder return decline of 33.32%, while the 5 year total shareholder return shows a decline of 76.95%, indicating that pressure has built over...
OM:CLAS B
OM:CLAS BSpecialty Retail

Do Clas Ohlson’s (OM:CLAS B) Rising Earnings Justify Its Reluctance to Pursue Acquisitions?

In March 2026, Clas Ohlson AB reported third-quarter sales of SEK 4,079.7 million and net income of SEK 514.1 million, alongside nine‑month sales of SEK 9,903.2 million and net income of SEK 1,030.2 million, all higher than the same period a year earlier. Management also reiterated that mergers and acquisitions remain an option, but emphasized a high threshold for potential targets and no immediate deals in sight, highlighting a disciplined approach to expansion alongside the earnings...
OM:PDX
OM:PDXEntertainment

Paradox Interactive (OM:PDX) Valuation Check After Fresh Content Rollouts For Cities Skylines II And Victoria 3

Paradox Interactive (OM:PDX) has been active on the content front, releasing new Creator Packs and radio stations for Cities: Skylines II, alongside an anniversary patch and a fresh expansion roadmap for Victoria 3. See our latest analysis for Paradox Interactive. Despite active content releases for Cities: Skylines II and Victoria 3, Paradox Interactive’s latest share price of SEK117.2 reflects a 90 day share price return decline of 26.52% and a 1 year total shareholder return decline of...
OM:SAAB B
OM:SAAB BAerospace & Defense

Saab (OM:SAAB B) Valuation Check As New AI Partnership Targets GlobalEye Growth

Saab (OM:SAAB B) has signed a Memorandum of Understanding with Canadian AI firm Cohere, aiming to apply advanced artificial intelligence to its GlobalEye offering for Canadian and other international operators. See our latest analysis for Saab. Despite the recent MOU with Cohere and other March announcements on naval reorganisation and investor conference activity, Saab's 7 day share price return of 7.19% and 30 day share price return of 4.60% contrast with a stronger 90 day share price...